Therapeutic Benefits

  • Reduced time in the ICU “30 minutes of IPV led to a significant decrease in rate, an increase in PaO2 and a decrease in PaCO2 (p<0.05). Hospital stay was significantly shorter in the IPV group than the control group (6.8±1.0 vs. 7.9±1.3 days, (p<0.05)” Antonaglia, V, Lucangelo, U, Zin, WA, et al., Crit Care Med, 2006 vol. 34(12) pp. 2940-5
  • 50% less incidence of pneumonia, improved P/F ratio. “At 15 days the tracheostomized patients on the IPV® had a significantly better PaO2 / FIO2 and a higher maximal expiratory pressure. After follow-up this group also had a lower incidence of pneumonia.” Clini, EM, Antonti, FD, Vitacca, M et al., Intensive Care Med 2006 vol. 32(12) pp. 1994-2001
  • Improved management of exacerbations. Vargas et al. J Crit Care, 2009 vol. 24(2) pp. 212-9